Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma. The gene discussed is RAD21; the disease is intrahepatic cholangiocarcinoma.